Navigation Links
Focus on glaucoma origins continues path toward potential cure
Date:1/17/2012

Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent.

New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.

Glaucoma is typically triggered when fluid is unable to circulate freely through the eye's trabecular meshwork (TM) tissue. Intraocular pressure rises and damages the retina and optic nerve, which causes vision loss. In certain cases of glaucoma, this blockage results from a build-up of the protein myocilin. Georgia Tech Chemistry and Biochemistry Assistant Professor Raquel Lieberman focused on examining the structural properties of these myocilin deposits.

"We were surprised to discover that both genetically defected as well as normal, or wild-type (WT), myocilin are readily triggered to produce very stable fibrous residue containing a pathogenic material called amyloid," said Lieberman, whose work was published in the most recent Journal of Molecular Biology.

Amyloid formation, in which a protein is converted from its normal form into fibers, is recognized as a major contributor to numerous non-ocular disorders, including Alzheimer's, certain forms of diabetes and Mad Cow disease (in cattle). Scientists are currently studying ways to destroy amyloid fibrils as an option for treating these diseases. Further research, based on Lieberman's findings, could potentially result in drugs that prevent or stop myocilin amyloid formation or destroy existing fibrils in glaucoma patients.

Until this point, amyloids linked to glaucoma had been restricted to the retinal area. In those cases, amyloids kill retina cells, leading to vision loss, but don't affect intraocular pressure.

"The amyloid-containing myocili
'/>"/>

Contact: Jason Maderer
maderer@gatech.edu
404-385-2966
Georgia Institute of Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Lung cancer conference to focus on new diagnostic techniques, potential treatments
2. Predictive health symposium will focus on human microbiome
3. Conservationists call for increased focus on coastal ecosystems
4. New book from NJIT professor focuses on art, science and evolution
5. Focus on fats
6. First NIH-funded personalized drug development center in US will focus on muscle disease
7. Fate of lakes focus of international meeting in Sunapee, N.H.
8. Journal focuses on Savannah River National Labratory, Chernobyl Laboratory collaboration
9. Researchers develop optimal algorithm for determining focus error in eyes and cameras
10. International pharmacogenomics conference to focus on better drug treatment based on genetics
11. October 2011 conference focuses on the role of gender in cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Focus on glaucoma origins continues path toward potential cure
(Date:7/23/2014)... the world by 2050, according to one of the ... (IPCC), may be advantageous to the physiology and the ... forage plants such as Stylosanthes capitata Vogel , ... such as Brazil., The conclusion is from a study ... at the Ribeiro Preto Faculty of Philosophy, Sciences and ...
(Date:7/23/2014)... MA -- What do mollusks, starfish, and corals ... habitat, they are all calcifiersorganisms that use calcium ... and shells for stability and protection. , The ... published by the Marine Biological Laboratory, addresses the ... changes worldwide. , As atmospheric carbon dioxide rises, ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4Calcification in changing oceans explored in special issue of The Biological Bulletin 2MedNet Appoints Clareece West As Chief Operating Officer 2
... Nanoparticles will soon be used as tiny shuttles to ... a more targeted way than was possible in the ... the nanoparticles in medicine, concerns have arisen about their ... nanoparticles and their toxicity rely on the ability of ...
... Mass. April 28, 2011 A project to use ... $100,000 grant from The Bill & Melinda Gates Foundation today. ... of the Harvard School of Engineering and Applied Sciences (SEAS) ... aim is to develop a Microbial Fuel Cell-based charger that ...
... One of the most critical tasks that a dividing ... set of genetic information to each new daughter cell. Now, ... issue of the journal Cell , provides fascinating new ... segregation of human chromosomes during cell division. During ...
Cached Biology News: Inverting a standard experiment sometimes produces different results 2 Inverting a standard experiment sometimes produces different results 3Harvard's engineering school receives $100,000 Grand Challenges Explorations grant 2Harvard's engineering school receives $100,000 Grand Challenges Explorations grant 3New insight into chromosome segregation: Centromere-independent kinetochore assembly 2
(Date:7/23/2014)... July 23, 2014 a2z Inc. announces ... Mobile App, AACC Pathfinder, in its 2014 Annual ... annual meeting is planned for July 29-31, 2014 in ... to be to connect with global leaders in clinical ... and other areas of breaking science in laboratory medicine. ...
(Date:7/22/2014)... Web) July 21, 2014 (PRWEB) July 23, 2014 ... Biomaterials, at Rutgers University. , The goal ... ideas across the full spectrum of scientists working ... research and development topics that represent the most ... been programmed to:,     Provide faculty ...
(Date:7/22/2014)... and Technology (NIST) and California Institute of Technology ... atomic clock that is based on a chip-scale ... clock, featured on the cover of the inaugural ... is the first demonstration of all-optical control of ... frequencies to lower microwave frequencies. (Optical frequencies are ...
(Date:7/22/2014)... , July 22, 2014   BioTE ... therapy using natural, bio-identical hormone pellets, today announced ... MD to the company.   Dr. Rouzier is joining ... physician.      Dr. Rouzier was residency ... UCLA and is a board certified emergency physician ...
Breaking Biology Technology:AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2'Comb on a chip' powers new NIST/Caltech atomic clock design 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3
...  Signaling a further commitment to expand its business model in ... of the largest imaging and cardiac safety core labs ... the opening of an office in Tokyo, Japan under the ... "We are pleased to announce the creation of our new ...
... Wis., Jan. 16, 2012 PuraMed BioScience, Inc. (OTCBB:PMBS) ... Baacke, CPA, to the position of Chief Financial Officer. ... the Corporate Controller for PuraMed BioScience, Inc. gaining extensive ... came to PuraMed after holding a supervisory position at ...
... Regenesis Biomedical, Inc., a medical technology company that ... Scott Brooks has joined the company in the ... is responsible for helping scale the organization,s capabilities ... (Logo: http://photos.prnewswire.com/prnh/20120109/LA31405LOGO ) ...
Cached Biology Technology:CoreLab Partners Opens Office in Tokyo, Japan 2PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO 2Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer 2
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
... Human serum is obtained from normal human ... by a test for Human Immunodeficiency Virus ... Virus (Anti-HIV 1/2), Hepatitis C Virus (HCV), ... (HbsAg) and Non-reactive by a screening test ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
Values of steady state parameters for enzyme activities are determined....
Biology Products: